IGI Logo

CORONA Remedies is currently trading at Rs. 1693.90, up by 19.00 points or 1.13% from its previous closing of Rs. 1,674.90 on the BSE.

The scrip opened at Rs. 1700.00 and has touched a high and low of Rs. 1700.95 and Rs. 1688.55 respectively. So far 850 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1951.30 on 12-May-2026 and a 52 week low of Rs. 1336.95 on 23-Dec-2025.

Last one week high and low of the scrip stood at Rs. 1,951.30 and Rs. 1,603.95 respectively. The current market cap of the company is Rs. 10,359.91 crore.

The promoters holding in the company stood at 69.00%, while Institutions and Non-Institutions held 9.27% and 21.74% respectively.

CORONA Remedies has received European Union Good Manufacturing Practice (EU-GMP) Compliance Certification for its Hormone manufacturing facility and renewed EU-GMP approval for its Oral Solid Dosage (OSD) manufacturing facility at Bhayla in Ahmedabad.

These significant milestones further strengthen CORONA’s global manufacturing and quality credentials, reaffirming its commitment to world-class quality systems, scientific excellence, and manufacturing capabilities aligned with international standards. Achieved with exceptional speed, these accreditations reflect CORONA’s strong quality culture, robust compliance framework, and operational excellence, marking a defining step in its journey to become a globally trusted partner in Hormone & other therapies.